Correlation Between Viscofan and Laboratorios Farmaceuticos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viscofan and Laboratorios Farmaceuticos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viscofan and Laboratorios Farmaceuticos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viscofan and Laboratorios Farmaceuticos ROVI, you can compare the effects of market volatilities on Viscofan and Laboratorios Farmaceuticos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viscofan with a short position of Laboratorios Farmaceuticos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viscofan and Laboratorios Farmaceuticos.

Diversification Opportunities for Viscofan and Laboratorios Farmaceuticos

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viscofan and Laboratorios is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Viscofan and Laboratorios Farmaceuticos ROV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Laboratorios Farmaceuticos and Viscofan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viscofan are associated (or correlated) with Laboratorios Farmaceuticos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Laboratorios Farmaceuticos has no effect on the direction of Viscofan i.e., Viscofan and Laboratorios Farmaceuticos go up and down completely randomly.

Pair Corralation between Viscofan and Laboratorios Farmaceuticos

Assuming the 90 days trading horizon Viscofan is expected to generate 0.26 times more return on investment than Laboratorios Farmaceuticos. However, Viscofan is 3.9 times less risky than Laboratorios Farmaceuticos. It trades about 0.08 of its potential returns per unit of risk. Laboratorios Farmaceuticos ROVI is currently generating about -0.25 per unit of risk. If you would invest  6,025  in Viscofan on September 1, 2024 and sell it today you would earn a total of  85.00  from holding Viscofan or generate 1.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Viscofan  vs.  Laboratorios Farmaceuticos ROV

 Performance 
       Timeline  
Viscofan 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Viscofan are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Viscofan is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Laboratorios Farmaceuticos 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Laboratorios Farmaceuticos ROVI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Viscofan and Laboratorios Farmaceuticos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viscofan and Laboratorios Farmaceuticos

The main advantage of trading using opposite Viscofan and Laboratorios Farmaceuticos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viscofan position performs unexpectedly, Laboratorios Farmaceuticos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Laboratorios Farmaceuticos will offset losses from the drop in Laboratorios Farmaceuticos' long position.
The idea behind Viscofan and Laboratorios Farmaceuticos ROVI pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio